Trent Carrier

Director de Operaciones en L7 Informatics, Inc. .

Commercial Services

Technology Services

Health Technology

Perfil

Trent Carrier is associated with multiple firms in the biotech industry.
He is currently the Chief Executive Officer and Director at CytoSen Therapeutics, Inc., Executive Director-Business Strategy at Biologics Consulting Group, Inc., Director at NERx Biosciences, Inc., and Chief Operating Officer at L7 Informatics, Inc.

Cargos activos de Trent Carrier

Empresas	Cargo	Inicio
Biologics Consulting Group, Inc. Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA.	Corporate Officer/Principal	12/08/2011
L7 Informatics, Inc. L7 Informatics, Inc. Packaged SoftwareTechnology Services L7 Informatics, Inc. provides integrated informatics platform for laboratory operations. The firm''s solutions include EnterpriseScience Platform, Genomic Cloud, BioBuilds and custom solutions. The company was founded by Christopher Mueller in 2011 and is headquartered in Austin, TX.	Director de Operaciones	01/10/2019
NERx Biosciences, Inc. NERx Biosciences, Inc. BiotechnologyHealth Technology NERx Biosciences, Inc. engages in the discovery and development of targeted therapeutics for cancer. The firm specializes in early development of novel biopharmaceutical compounds. It focuses on new generation of cancer drugs that target specific cellular processes not currently being exploited as cancer therapies. The company was founded by John Turchi and Robert Feltgen in 2009 and is headquartered in Indianapolis, IN.	Director/Miembro de la Junta	-

Todos los cargos activos de Trent Carrier

Antiguos cargos conocidos de Trent Carrier.

Empresas	Cargo	Fin
CytoSen Therapeutics, Inc. CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL.	Director Ejecutivo	-

Ver el detalle de la experiencia de Trent Carrier.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Trent Carrier.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Biologics Consulting Group, Inc. Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Biologics Consulting Group, Inc. provides regulatory and product development advisory services for drugs and device products. It specializes in the preparation and review of CBER, CDER and CDRH regulatory applications, facility inspection, process validation packages, and electronic submissions. The company was founded by James G. Kenimer in 1993 and is headquartered in Alexandria, VA.	Commercial Services
L7 Informatics, Inc. L7 Informatics, Inc. Packaged SoftwareTechnology Services L7 Informatics, Inc. provides integrated informatics platform for laboratory operations. The firm''s solutions include EnterpriseScience Platform, Genomic Cloud, BioBuilds and custom solutions. The company was founded by Christopher Mueller in 2011 and is headquartered in Austin, TX.	Technology Services
CytoSen Therapeutics, Inc. CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CytoSen Therapeutics, Inc. develops natural killer (NK) cell therapeutics for cancer. It offers nanoparticle processing technology which enables improved ex vivo expansion and activation of NK-cells supporting multiple high dose infusions with anti-cancer cytotoxicity. The company was founded by Stefan O. Ciurea, Dean Lee and Robert Igarashi and is headquartered in Orlando, FL.	Commercial Services
NERx Biosciences, Inc. NERx Biosciences, Inc. BiotechnologyHealth Technology NERx Biosciences, Inc. engages in the discovery and development of targeted therapeutics for cancer. The firm specializes in early development of novel biopharmaceutical compounds. It focuses on new generation of cancer drugs that target specific cellular processes not currently being exploited as cancer therapies. The company was founded by John Turchi and Robert Feltgen in 2009 and is headquartered in Indianapolis, IN.	Health Technology

Ver las conexiones de la empresa